Barely three years since its coronavirus vaccine helped stem the pandemic, Pfizer’s stock has lost 50 percent of its value ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.03% of ...

The new drug would allow patients to produce the needed clotting protein for an extended period, reducing the need for ...

A Pfizer Covid booster vaccination gave a fit 54-year-old chronic pain, NHS doctors found.Larry Lowe, from Omagh in Northern ...

据知情人士向媒体透露，激进投资者Starboard Value已在辉瑞公司（Pfizer）持有约10亿美元的股份，并希望对该公司进行变革以扭转目前的困境。受此消息推动，辉瑞股价周一一度涨超4.4%。 数据显示，截至上周五，辉瑞的市值约为1620亿美元 ...

The approval of Hympavzi Friday was a dose of good news for Pfizer, which is dealing with research setbacks and a challenge from an activist investor.

With valuations growing across the stock market and the biopharma sector, it's only natural for value-sensitive investors to be looking for bargains all the more intently. On average, the ...

▎药明康德内容团队编辑‍今天，美国FDA批准辉瑞（Pfizer）药品Hympavzi（marstacimab）用于常规预防或减少12岁及以上血友病A和血友病B成人和儿童患者的出血，这些患者体内不含凝血因子VIII与IX抑制剂（中和抗体）。根据新闻稿， ...

▎药明康德内容团队编辑辉瑞（Pfizer）今天公布TALAPRO-2临床3期研究的预定顶线分析积极结果。分析显示，与活性对照药物相比，其多腺苷二磷酸核糖聚合酶（PARP）抑制剂Talzenna（talazoparib）与雄激素受体途径抑制剂（ARPI ...

当地时间10月11日，美国FDA批准辉瑞（Pfizer）药品Hympavzi（marstacimab）用于常规预防或减少12岁及以上血友病A和血友病B成人和儿童患者的出血，这些患者体内不含凝血因子VIII与IX抑制剂（中和抗体）。

辉瑞 ( 28.94, -0.15, -0.52%) 公司（Pfizer）将从出售Haleon的股票和Haleon的股票回购中获得总计约26.6亿英镑（约合35.6亿美元）。 高盛 ( 495.11, -3.40, -0.68%) ...

10月11日，黑龙江省医保局官微曝光了3例违法违规使用医疗保障基金的典型案例，涉及串换项目收费、重复收费、超标准收费、过度检查、将不属于医疗保障基金支付范围的医药费用纳入医疗保障基金结算等违法违规行为。